The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Heparin Induced Thrombocytopenia Market - 2024-2033
US$ 2,999.00
The Heparin Induced Thrombocytopenia Market was valued at US$ 10.37 billion in 2024 and is anticipated to reach US$ 16.48 billion by 2033, at a CAGR of 0.053 from 2026 to 2032. The report delivers in-...
January 2025
223 pages
Polycythemia Market - 2024-2033
US$ 2,999.00
The Polycythemia Market was valued at US$ 5.89 billion in 2024 and is anticipated to reach US$ 12.41 billion by 2033, at a CAGR of 0.067 from 2026 to 2032. The report delivers in-depth insights into k...
January 2025
243 pages
Iron Deficiency Anemia Market - 2024-2032
US$ 2,999.00
The Iron Deficiency Anemia Market was valued at US$ 4.39 billion in 2024 and is anticipated to reach US$ 7.33 billion by 2032, at a CAGR of 0.068 from 2026 to 2032. The report delivers in-depth insigh...
January 2025
220 pages
Global Tumor Necrosis Factor Inhibitor Drugs Market Size Study by Product (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars), by Application (Rheumatoid Arthritis, Psoriasis, Ulcerative Colitis, Crohn’s Disease, and Others), by Sales Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), and Regional Forecasts 2022-2032
US$ 3,750.00
TNF inhibitors are pivotal in treating autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriasis, and Crohn’s disease, by targeting and inhibiting the action of tumor necrosis...
January 2025
285 pages
Global Artificial Intelligence in Drug Discovery Market Size Study, by Application (Drug Optimization and Repurposing, Preclinical Testing, Others), by Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Others), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Artificial Intelligence (AI) in Drug Discovery Market was valued at approximately USD 1.6 billion in 2023 and is projected to expand at a robust CAGR of 29.7% during the forecast period 202...
January 2025
285 pages
Global Post-traumatic Stress Disorder Treatment Market Size study, by Drug Class (Antidepressants, Anti-anxiety, Antipsychotics, Other Drug Class), by Demographics (Adult, Children, Geriatric), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Other Pharmacies) and Regional Forecasts 2022-2032
US$ 3,750.00
The global post-traumatic stress disorder (PTSD) treatment market was valued at USD 2.14 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.08% over the forecast p...
January 2025
285 pages
Chronic Inflammation Treatment Market 2026
US$ 2,999.00
The Chronic Inflammation Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
January 2025
220 pages
Growth Hormone Deficiency Treatment Market - 2024-2032
US$ 2,999.00
The Growth Hormone Deficiency Treatment Market was valued at US$ 6.9 billion in 2024 and is anticipated to reach US$ 9.2 billion by 2032, at a CAGR of 0.121 from 2026 to 2032. The report delivers in-d...
January 2025
210 pages
Global Age-related Macular Degeneration (AMD) Drugs Market Size Study, by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), by Molecule (Ranibizumab, Aflibercept, Faricimab), by Approval Type (Biologic, Biosimilar), by Type of AMD, and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Age-related Macular Degeneration (AMD) Drugs Market is currently valued at approximately USD 9.45 billion in 2023 and is forecasted to grow at an impressive CAGR of 10.70% over the forecast...
January 2025
285 pages
OTC Drugs, Medical Devices and Diagnostics: Global Markets
US$ 4,650.00
Report : The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics...
January 2025
139 pages
Active Pharmaceutical ingredient Market Size, Share, and Analysis, By Type (Innovative API and Generic API), By Manufacturer (Captive API Manufacturer and Merchant API Manufacturer), By Synthesis (Synthetic APIs and Biotech APIs), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Urology, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
US$ 5,250.00
Active Pharmaceutical ingredient Market is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% during the forecast span from 2024 to 2034. In 2023, the market size was assessed at USD 239....
January 2025
646 pages
Global Antiplatelet Market: Analysis By Drug Class (Adenosine Diphosphate Receptor Inhibitors, Irreversible Inhibitors Cyclooxygenase, and Other Drug Classes), By Route of Administration (Oral and Injectable), By Distribution Channel (Drug Stores, Hospital Pharmacies, and Online Stores), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,250.00
Antiplatelet drugs prevent platelets from sticking together and decrease the body’s ability to form blood clots. These medications are used to treat, and may help prevent, heart attack, abnormal heart...
November 2024
146 pages
Prescription Drugs Markets in China
US$ 4,000.00
China's demand for Prescription Drugs has grown at a fast pace in the past decade. In the next ... ) and/or US dollars. Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous ...
October 2024
217 pages
Prescription Drugs Industry Forecasts - China Focus
US$ 1,800.00
This study focuses on China’s Prescription Drugs industry forecasts. In the two past decades, the ... -term forecasts through 2023 and 2028 are presented. The primary and secondary research is done in China in ... reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find ...
October 2024
93 pages
Prescription Drugs Companies in China
US$ 1,800.00
This study focuses on China’s Prescription Drugs industry assessments and company profiles. In the two past decades, the industry has been ... 1,500 reports focusing on the Chinese markets, industry forecasts and company profiles. We provide hard-to-find market data and analyses. Our ...
October 2024
73 pages
Global Heart Failure Therapeutics Market Size Study, by Treatment (Medical Devices, Medicines, Surgery), by Type (Diagnosis, Prognosis), by Stage (Stage A, Stage B, Stage C, Stage D), by End User (Clinic, Hospital, Medical Research Organization), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Heart Failure Therapeutics Market is valued at approximately USD 23.98 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 10.46% over the forecast period 202...
October 2024
285 pages
Alzheimer's Drugs – A Global Market Overview
US$ 4,500.00
Alzheimer's Drugs Market Trends and Outlook Alzheimer's disease is a degenerative neurological condition that progresses over time and is the primary cause of dementia, typically impacting individuals...
September 2024
253 pages
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
US$ 4,950.00
The Age-Related Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029....
September 2024
336 pages
Antibody Drugs: Technologies and Global Markets
US$ 4,650.00
... growth rate (CAGR) of 6.3% from 2017 through 2022. The global antibody drugs market for autoimmune diseases reached $37.3 billion in 2016. The market ... $37.5 billion in 2017, at a CAGR of 5.1% from 2017 through 2022. The global antibody drugs market for lymphoma reached $37.3 billion in 2016. The market should ...
September 2024
156 pages
Drug Discovery Technologies
US$ 4,650.00
... among others. Key players in the drug discovery market include Thermo Fisher Scientific, Agilent Technologies Inc., Shimadzu Corp., Bruker Corp., ... 23 additional tables. An overview of the global markets for drug discovery technologies. Analyses of global market trends with data from 2015, 2016, and 2017, ...
September 2024
192 pages
UAE Over the Counter (OTC) Drugs Market By Product Type (Cough, Cold and Flu, Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2019-2029F
US$ 3,500.00
UAE Over the Counter (OTC) Drugs Market was valued at USD 2.79 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.73% through 2029. Over the Cou...
August 2024
83 pages
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
US$ 4,950.00
... in the emerging markets, and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of immunotherapy drugs market. Based on type of drugs, the market is segmented ... the largest market share in the immunotherapy drugs market, by type of drugs in 2016. On the other hand, checkpoint inhibitors segment is expected to be the fastest growing segment in the immunotherapy drugs market, by type of drugs, in 2016 ...
July 2024
335 pages
Drugs and Diagnostics for Hematological Disorders: Global Markets
US$ 4,650.00
This BCC Research report presents an analysis of the current state of hematological disorders and blood cancers, therapy and technology, and utilization of the various therapeutic and diagnostic modalities to prevent and treat these disorders. Forecast provided through 2020.
July 2024
133 pages
Japan Drugstore Market: Analysis By Product Category (Food, Household Utensils, Beauty Care, OTC Drugs, Dispensing, Health Care and Others), By Area of Operation (Stores with Floor Areas of 300m2 or Above and Stores with Floor Areas of Less Than 300m2), By Number of Stores, Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,250.00
A drugstore is a retail store that offers prescription medications, over-the-counter (OTC) drugs, health and wellness products, personal care items, and often, groceries and household essentials. In J...
June 2024
95 pages
Global Weight Loss Drugs Market: Analysis By Product Type (Powders and Pills, Liquids, and Injection), By Drug Type (Prescription Drugs and Over The Counter (OTC) Drugs), By Distribution Channel (Online and Offline), By End User (Under 18 Years, 18-40 Years, 40-50 Years and Above 50 Years), By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,250.00
In an era marked by surging obesity rates and prevalent lifestyle-related illnesses, the quest for effective weight loss remedies has become increasingly urgent. Despite concerted efforts in diet and...
April 2024
152 pages
Epinephrine Market By Product Type (Auto-Injector, Prefilled Syringe, Others), By Application (Anaphylaxis, Cardiac Arrest, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2022 - 2032
US$ 3,570.00
The epinephrine market was valued at $2.6 billion in 2022 and is projected to reach $4.4 billion by 2032, registering a CAGR of 5.6% from 2023 to 2032. Epinephrine, also known as adrenaline, is a horm...
March 2024
266 pages
